Pedrano, Vitaliana D.
HRN: 22-09-01 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/28/2023
METRONIDAZOLE 500MG (TAB)
05/28/2023
06/04/2023
IV
500mg
TID
Helicobacter Pylori Infection
Checking Final Appropriateness
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes